Quarterly Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7595165

Concept 2022-01-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
As at
2020-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-349,379,000 JPY
-780,840,000 JPY
Depreciation
13,604,000 JPY
9,079,000 JPY
Impairment losses
42,948,000 JPY
6,108,000 JPY
Interest expenses
3,063,000 JPY
2,194,000 JPY
Foreign exchange losses (gains)
-20,351,000 JPY
-5,737,000 JPY
Decrease (increase) in trade receivables
1,125,012,000 JPY
58,195,000 JPY
Decrease (increase) in inventories
-2,693,000 JPY
-6,079,000 JPY
Increase (decrease) in trade payables
-1,814,000 JPY
-1,437,000 JPY
Other, net
1,732,000 JPY
8,716,000 JPY
Subtotal
594,696,000 JPY
-1,012,370,000 JPY
Interest paid
-2,954,000 JPY
-2,104,000 JPY
Net cash provided by (used in) operating activities
585,341,000 JPY
-963,337,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-57,614,000 JPY
-34,184,000 JPY
Other, net
305,000 JPY
JPY
Net cash provided by (used in) investing activities
-57,309,000 JPY
-34,339,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-120,012,000 JPY
-88,273,000 JPY
Redemption of bonds
-14,014,000 JPY
-14,014,000 JPY
Net cash provided by (used in) financing activities
166,348,000 JPY
-102,287,000 JPY
Effect of exchange rate change on cash and cash equivalents
172,483,000 JPY
13,891,000 JPY
Net increase (decrease) in cash and cash equivalents
866,864,000 JPY
-1,086,072,000 JPY
Cash and cash equivalents
4,684,699,000 JPY
3,817,834,000 JPY
3,213,070,000 JPY
4,299,142,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.